4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaguer, P; Chen, I; Daniel, K; Gillesby, B; Joyeux, A; Moore, M; Mustain, M; Safe, S; Zacharewski, T | 1 |
1 other study(ies) available for 4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl and Adenocarcinoma
Article | Year |
---|---|
Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Topics: Adenocarcinoma; Animals; Binding, Competitive; Breast Neoplasms; Chloramphenicol O-Acetyltransferase; Estrogen Antagonists; Estrogens; Female; HeLa Cells; Humans; Luciferases; Molecular Structure; Neoplasms, Hormone-Dependent; Polychlorinated Biphenyls; Promoter Regions, Genetic; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Uterus; Vitellogenins | 1997 |